Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats.

Stroke; a Journal of Cerebral Circulation
C G MarkgrafM D Linnik

Abstract

Stroke patients often experience a significant temporal delay between the onset of ischemia and the time to initiation of therapy. Thus, there is a need for neuroprotectants with a long therapeutic window of opportunity. The efficacy of a potent, central nervous system-penetrating calpain inhibitor (MDL 28,170) was evaluated in a temporary model of focal cerebral ischemia to determine the window of opportunity for intracellular protease inhibition. An ex vivo brain protease inhibition assay established pharmacodynamic dosing parameters for MDL 28,170. Middle cerebral artery (MCA) occlusion was accomplished by advancing a monofilament through the internal carotid artery to the origin of the MCA. Postmortem infarct volumes were determined by quantitative image analysis of triphenyltetrazolium-stained brain sections. Maximal inhibition of brain protease activity was observed 30 minutes after injection of MDL 28,170 with an estimated pharmacodynamic half-life of 2 hours. MDL 28,170 caused a dose-dependent reduction in infarct volume when administered 30 minutes after MCA occlusion. A window of opportunity study was conducted to determine the maximal delay between the onset of ischemia and the initiation of efficacious therapy. MDL ...Continue Reading

References

Dec 10, 1991·European Journal of Pharmacology·L ArlinghausK S Lee
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K S LeeG Lynch
Apr 1, 1991·Trends in Biochemical Sciences·S Mehdi
Jul 1, 1991·Physiological Reviews·D E Croall, G N DeMartino
Feb 1, 1986·Annals of Neurology·S M Rothman, J W Olney
Dec 14, 1995·The New England Journal of Medicine·UNKNOWN National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Mar 24, 1995·The Journal of Biological Chemistry·S J MartinD R Green
Jul 1, 1995·Stroke; a Journal of Cerebral Circulation·J R BrorsonR J Miller
Nov 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R T BartusG Lynch
Nov 22, 1993·Archives of Internal Medicine·W G BarsanJ R Marler
May 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H YaoR Busto
Feb 1, 1995·Current Opinion in Neurology·W A Pulsinelli
Nov 1, 1994·Trends in Pharmacological Sciences·K K Wang, P W Yuen
Jul 1, 1994·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R T BartusJ A Straub
May 1, 1994·Journal of Cellular Physiology·M K SquìerJ J Cohen
Mar 1, 1996·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·C DuD W Choi
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·H HaraM A Moskowitz
May 26, 1997·European Journal of Pharmacology·J M Ren, S P Finklestein

❮ Previous
Next ❯

Citations

Mar 19, 1999·Journal of Neuroscience Research·K KitagawaM Hori
Dec 21, 2000·Current Atherosclerosis Reports·S H AhmedC Y Hsu
Apr 5, 2005·Brain Research·Atsushi KambeTakashi Watanabe
May 10, 2005·Brain Research·Kin ChiuJacky Man Kwong Kwong
Feb 5, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Kathryn E SaatmanRamesh Raghupathi
Feb 28, 2004·Thrombosis Research·Martin LiebetrauGerhard F Hamann
Aug 12, 1999·European Journal of Pharmacology·D DewarJ McCulloch
May 10, 2003·Brain Research. Brain Research Reviews·Swapan K RayNaren L Banik
Jan 13, 2000·Trends in Neurosciences·K K Wang
Feb 19, 2002·Neurochemistry International·Neil R Sims, Michelle F Anderson
Apr 8, 1999·Early Human Development·A J Gunn, T R Gunn
Sep 30, 2000·Bioorganic & Medicinal Chemistry Letters·W LubischA Möller
May 7, 2002·Bioorganic & Medicinal Chemistry Letters·W Lubisch, A Möller
Feb 18, 1999·Bioorganic & Medicinal Chemistry Letters·M R AngelastroN P Peet
Aug 23, 2001·Trends in Molecular Medicine·Y Huang, K K Wang
Mar 29, 2002·Clinical and Experimental Pharmacology & Physiology·Thanh G PhanGeoffrey A Donnan
Jan 24, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yoshihisa ShirasakiHiroyuki Miyashita
Feb 18, 2010·Genes & Development·Homaira NawabiValérie Castellani
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Xiuli LiuRick G Schnellmann
Sep 21, 2000·The Journal of Clinical Investigation·J M LeeD W Choi
Aug 2, 2011·Neurological Research·William M Armstead, Ramesh Raghupathi
Oct 23, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Dorothy P SchaferMatthew N Rasband
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Lise A Labiche, James C Grotta
Jul 25, 2000·Biochemical and Biophysical Research Communications·R NathK K Wang
Jun 26, 2001·Experimental Neurology·R W NeumarR Siman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.